EGM
AKCA

Engineers Gate Manager’s Akcea Therapeutics Inc AKCA Stock Holding History

Engineers Gate Manager’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,121
Closed -$145K – 2090
2020
Q1 		$145K Sell
10,121
-6,799
-40% -$112K 0.01% 1345
2019
Q4 		$287K Buy
+16,920
New +$315K 0.01% 1278

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Engineers Gate Manager's AKCA Position: Q2 2020 in Review

Engineers Gate Manager sold out of Akcea Therapeutics Inc (AKCA) in Q2 2020, closing a stake of 10,121 shares — an estimated $145K sold.

Engineers Gate Manager first reported a position in AKCA in Q4 2019 and held it in 2 quarters. The position peaked at $287K in Q4 2019. 84 funds tracked by Wall St. Rank hold AKCA as of Q2 2020.

  • Engineers Gate Manager reported no remaining Akcea Therapeutics Inc position as of Q2 2020 after selling out during the quarter.
  • Engineers Gate Manager sold 10,121 Akcea Therapeutics Inc shares in Q2 2020, an estimated $145K.
  • Engineers Gate Manager first reported a position in Akcea Therapeutics Inc in Q4 2019 and held it in 2 quarters.
  • Engineers Gate Manager's Akcea Therapeutics Inc position peaked at $287K in Q4 2019.
  • 84 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q2 2020.

Based on Engineers Gate Manager's 13F filing for Q2 2020, filed 17 Aug 2020.